DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Iterum Therapeutics Q4 EPS $(1.59) Down From $(1.19) YoY

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(1.59) per share. This is a 33.61 percent decrease over losses of $(1.19) per share from the same period last year.

Benzinga · 03/12/2020 10:46

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(1.59) per share. This is a 33.61 percent decrease over losses of $(1.19) per share from the same period last year.